Introduction
============

In the critically ill, a higher admission blood lactate concentration is associated with a higher risk of death \[[@B1]-[@B8]\]. We recently reported that even within the current \'normal range\' (\< 2.00 mmol.L^-1^) a higher admission blood lactate concentration is associated with significantly increased hospital mortality \[[@B4]\], a finding which suggests that even the subtle perturbations of lactate homeostasis may be important.

An elevated blood lactate concentration (a \'static\' index) at any time point must be due to an increase in its production, a decrease in its clearance, or both. Likewise, an increasing blood lactate concentration (a \'dynamic\' index) must be due to increasing production, decreasing clearance, or both simultaneously \[[@B9]-[@B11]\]. Static derangements in lactate homeostasis during ICU stay have become established as clinically useful markers of increased risk of hospital and ICU mortality \[[@B1],[@B3],[@B4],[@B12]\]. However, dynamic indices of lactate homeostasis, which describe not only magnitude but also duration and trend over time, may be even more useful in predicting outcome. In support of this hypothesis, a number of small single centre observational studies, principally in patients with severe sepsis and septic shock, have suggested that early changes in blood lactate concentration may be useful in identifying those at high risk of death \[[@B5],[@B6],[@B13]-[@B16]\]. Furthermore, one interventional study (*n*= 348) has suggested that interventions aimed at targeting a dynamic reduction in lactate (20% per two hours for the first eight hours) in the critically ill with an abnormal admission lactate level may be associated with reduced organ failure and increased survival \[[@B17]\]. However, the association between dynamic changes in blood lactate concentration during the first 24 hours of ICU admission and mortality has not yet been investigated in a very large heterogeneous cohort of critically ill patients. Furthermore, to our knowledge no study has compared the ability of dynamic compared to static indices of lactate homeostasis to predict mortality in the critically ill.

To study this association, we examined the relationship between six indices of lactate homeostasis in the first 24 hours of ICU admission and both hospital and ICU mortality. Three indices were static: i) admission lactate (LAC~ADM~), ii) maximum lactate (LAC~MAX24~), iii) minimum lactate (LAC~MIN24~), and three were dynamic: iv) time weighted lactate (LAC~TW24~), v) absolute change in (delta) lactate (LAC~Δ24~) and vi) percentage change in lactate (LAC~%Δ24~).

Materials and methods
=====================

The data collection and data analysis for this study are part of ongoing de-identified data auditing processes across the participating hospitals, which have all waived the need for informed consent. The Austin Hospital Ethics Committee approved studies related to this database.

Study population and data sources
---------------------------------

The study population and data sources used in this study are similar to those previously reported by us, in a previous manuscript describing lactate homeostasis in the critically ill \[[@B4]\]. In brief, this four-centre retrospective investigation of a prospectively gathered intensive care database enrolled patients from January 2000 to October 2004. However, in this study a minimum of two lactate values collected over the first 24 hours were necessary for inclusion into the study, with the latter criteria needed to produce both a time weighted lactate (LAC~TW24~) and a change in lactate (LAC~Δ24~) over the first 24 hours.

The blood lactate concentration data used for this study were stored and retrieved electronically. We obtained age, sex, use of mechanical ventilation, reason for ICU admission (surgical and non-surgical, further classified as trauma, cardiac/vascular, gastrointestinal tract, neurological and thoracic/respiratory), and Acute Physiology and Chronic Health Evaluation (APACHE) II score \[[@B18]\] from the electronic data repositories of each ICU, using data prospectively collected as part of the Australian and New Zealand Intensive Care Society-Centre for Outcome and Resources Evaluation (ANZICS-CORE) quality assurance program \[[@B19]\].

The timing of lactate measurement (Rapilab, Bayer Australia, Sydney, NSW, Australia) was at the discretion of the managing critical care team. Laboratories in the participating hospitals comply with standards of the National Association of Testing Authorities \[[@B20]\] and the Royal College of Pathologists of Australia \[[@B21]\].

Statistical analysis
--------------------

To avoid the potential effect of surveillance bias due to the increased blood lactate monitoring in more severely ill patients, we calculated the time-weighted lactate concentration (LAC~TW24~). In brief, time weighted average lactate (Lac~TW~) is an index of lactate homeostasis that is proportional to the amount of time spent at each concentration in relation to the total period of time observed. It is determined by summing the mean value between consecutive time points multiplied by the period of time between consecutive time points and then dividing by the total time (see Figure [1](#F1){ref-type="fig"}). This method was modified from and used in accordance with an approach previously used by Finney *et al*. to describe hyperglycaemia \[[@B22]\].

![**Diagram describing the calculation of time weighted lactate (Lac~TW~)**.](cc10497-1){#F1}

The change in lactate over 24 hours (LAC~Δ24~) was calculated by regressing lactate against time for each individual patient, with the regression slope representing the projected change over a 24-hour period. To avoid undue influence from extreme outliers, the maximal and minimal slope values were capped in accordance with Tukey \[[@B23]\]. Values that were found to be more than three times the interquartile range to the left of the 25^th^percentile or to the right of the 75^th^percentile were considered to be extreme outliers. This resulted in a maximum increase or decrease in slope over the first 24 hours of 5 mmol.L^-1^. LAC~%Δ24~describes the change in lactate over a 24-hour period as the percentage change from the admission blood lactate concentration.

The primary outcomes for analysis were hospital and ICU mortality. We performed univariate analysis for comparison between groups according to hospital mortality status using chi-square test for proportions, Student *t*-tests for normally distributed outcomes and, otherwise, used Wilcoxon rank sum tests. We performed multivariate analysis with all available predictors of hospital mortality included in the models (gender, age, APACHE II, mechanical ventilation, surgical admission and diagnosis type). To account for changes in practice over the four-year period of the study, the patient admission date was included along with the specific hospital. To further account for surveillance bias, the number of lactate measurements collected over the first 24 hours was also included. After forcing all of the previous described variables into the multivariate model, both stepwise and backwards elimination procedures were used to determine which lactate indices could independently aid in the prediction of mortality. Six lactate indices specifically relating to the first 24 hours of ICU admission were considered: Three indices were static: i) admission lactate (LAC~ADM~), ii) maximum lactate (LAC~MAX24~), iii) minimum lactate (LAC~MIN24~), and three were dynamic: iv) time weighted lactate (LAC~TW24~), v) absolute change in (delta) lactate (LAC~Δ24~) and vi) percentage change in lactate (LAC~%Δ24~).

To determine if the relationship between lactate and mortality was consistent across patient subgroups and study hospitals, we examined interactions between measures of lactate and other variables in the model. To confirm that the potential relationships between lactate and mortality were linear in nature, measures of lactate were divided into quintiles and analysed as categorical variables, with quintiles chosen to provide a minimum of 1,000 patients per category. Goodness of fit was determined using the Hosmer and Lemeshow statistic. All analyses were performed using SAS version 9.2 (SAS Institute Inc., Cary, NC, USA). A two-sided *P*-value of 0.05 was considered to be statistically significant.

Having established which lactate variables had the strongest relationships with mortality, to then determine the true predictive capacity of these lactate variables, the data were randomly divided into two groups, with 50% of the data used as a derivation sample and the remaining 50% of the data used as a validation sample. Univariate models and multivariate models (with and without the inclusion of lactate) were constructed from the derivation sample for both hospital and ICU mortality. The prediction equations were then applied to the holdout sample and the improvement in the Area under the Receiver Operating Characteristic Curve (AUC-ROC) was recorded.

Results
=======

We studied a heterogeneous cohort of 7,155 critically ill patients of whom 5,041 had at least two measurements over the first 24 hours (median 7; range 2 to 34) and were included in the analysis. All indices of blood lactate concentration over the first 24 hours (LAC~ADM~, LAC~TW24~, LAC~MAX24~, LAC~MIN24~), were significantly higher in hospital non-survivors compared to survivors (Table [1](#T1){ref-type="table"}). The median decline in lactate over the first 24 hours (LAC~Δ24~) and the median percentage decline in lactate (LAC~%Δ24~) were significantly lower in non-survivors compared to survivors (Table [1](#T1){ref-type="table"}).

###### 

Comparison of hospital survivors vs.nonsurvivors

  ---------------------------------------------------------------------------------------------
  Variable                          Non survivors\          Survivors\              *P*-value
                                    (*n*= 974)              (*n*= 4,067)            
  --------------------------------- ----------------------- ----------------------- -----------
  Male sex                          59% (574)               62% (2,510)             0.11

  APACHE II score                   24.7 (8.0)              15.3 (6.7)              \< 0.0001

  Age (yr)                          65.7 (16.0)             59.7 (18.9)             \< 0.0001

  Mechanical ventilation rate       84% (817)               60% (2443)              \< 0.0001

  Surgical patients                 32% (307)               51% (2087)              \< 0.0001

  Diagnosis at admission                                                            

  Cardiac and vascular              27% (265)               24% (979)               0.04

  Thoracic and respiratory          20% (191)               18% (719)               0.16

  Trauma                            3% (27)                 8% (343)                \< 0.0001

  Neurological                      18% (175)               12% (485)               \< 0.0001

  Gastrointestinal tract diseases   13% (128)               21% (870)               \< 0.0001

  Other                             19% (188)               16% (671)               0.04

  Hospital stay (days)              10 (4 to 25)            15 (8 to 30)            \< 0.0001

  ICU stay (days)                   3.0 (2.0 to 8.0)        3.0 (2.0 to 5.2)        \< 0.0001

  Number of measurements            8 (6 to 10)             7 (5 to 9)              \< 0.0001

  LAC~TW24~(mmom.L^-1^)             2.20 (1.41 to 3.66)     1.41 (1.02 to 1.97)     \< 0.0001

  LAC~Δ24~(mmom.L^-1^)              -0.21 (-1.66 to 0.73)   -0.30 (-1.18 to 0.24)   0.009

  LAC~%Δ24~                         -13% (-49% to 42%)      -22% (-55% to 21%)      \< 0.0001

  LAC~ADM~(mmom.L^-1^)              2.36 (1.45 to 4.29)     1.6 (1.08 to 2.49)      \< 0.0001

  LAC~MIN24~(mmom.L^-1^)            1.34 (0.92 to 2.16)     1.00 (0.74 to 1.31)     \< 0.0001

  LAC~MAX24~(mmom.L^-1^)            3.44 (1.99 to 6.20)     2.02 (1.37 to 3.20)     \< 0.0001
  ---------------------------------------------------------------------------------------------

APACHE II, Acute Physiology and Chronic Health Evaluation II; LAC~ADM~, admission lactate; LAC~TW24~, time weighted lactate; LAC~MAX24~, maximum lactate; LAC~MIN24~, minimum lactate; LAC~Δ24~, delta lactate; LAC~%Δ24~, percentage change in lactatein the first 24 hours

Univariate analysis
-------------------

We assessed the ability of both static (LAC~MAX24~and LAC~MIN24~) and dynamic (LAC~TW~, LAC~Δ24~and LAC~Δ24%~) indices of lactate homeostasis in the first 24 hours to predict hospital and ICU mortality benchmarked against LAC~ADM~, the most commonly used static measure (Table [2](#T2){ref-type="table"}). The combination of LAC~TW~and LAC~Δ24~, which assesses duration, magnitude and trend of lactate derangement, resulted in the most significant increase in ability to predict hospital death (Table [2](#T2){ref-type="table"}).

###### 

Change in RAW (AUC-ROC) for indices of lactate homoeostasis in the first 24 hours and mortality

  \_NAME\_              Hosp AUC-RAW    *P*-value\*   ICU AUC-RAW     *P*-value\*
  --------------------- --------------- ------------- --------------- -------------
  LAC~ADM~              0.648 ± 0.014                 0.700 ± 0.017   
  LAC~Δ24%~             0.558 ± 0.016   0.0002        0.572 ± 0.022   \< 0.0001
  LAC~Δ24~              0.534 ± 0.016   \< 0.0001     0.542 ± 0.022   \< 0.0001
  LAC~MAX24~            0.694 ± 0.014   \< 0.0001     0.769 ± 0.016   \< 0.0001
  LAC~TW24~             0.705 ± 0.014   \< 0.0001     0.769 ± 0.016   \< 0.0001
  LAC~MIN24~            0.682 ± 0.014   0.002         0.723 ± 0.018   0.15
                                                                      
  LAC~TW~and LAC~Δ24~   0.710 ± 0.01    \< 0.0001     0.763 ± 0.01    \< 0.0001

\*compared to LAC~ADM~

AUC-RAW, Unadjusted Area Under Curve; LAC~ADM~, admission lactate; LAC~TW24~, time weighted lactate; LAC~MAX24~, maximum lactate; LAC~MIN24~, minimum lactate; LAC~Δ24~, delta lactate-change in lactate in the first 24 hours; LAC~%Δ24~, percentage delta lactate-percentage change in lactate in the first 24 hours Hosp, hospital mortality; ICU intensive care unit mortality

Multivariate analysis
---------------------

After adjusting for established predictors of mortality, the lactate variables that were independently the most predictive of hospital and ICU mortality were LAC~TW24~and LAC~Δ24~(Table [3](#T3){ref-type="table"}). For every one unit increase in LAC~Δ24~the risk of death increased by 15% (OR 1.15 (1.10 to 1.20) *P*\< 0.0001) for hospital mortality and 18% for ICU mortality (OR 1.18 (1.13 to 1.24) *P*\< 0.0001). When LAC~Δ24~was divided into quintiles the relationship between LAC~Δ24~and mortality also appeared to be well approximated by linearity (Figure [2](#F2){ref-type="fig"}). When the risk of death was calculated based on the slope of the LAC~Δ24~, an increasing blood lactate concentration (slope greater than 0 mmom.L^-1^.24 hours^-1^) was associated with a greater increase in risk of hospital and ICU death (OR 1.46 (1.23 to 1.74) *P*\< 0.0001 and OR 1.71 (1.37 to 2.13) *P*\< 0.0001, respectively). Furthermore, the risk of hospital death based on the slope of the LAC~Δ24~was greater in the increasing blood lactate concentration group (*n*= 1,879) and the mildly decreasing blood lactate concentration group (slope 0 to -1 mmom.L^-1^.24 hours^-1^, *n*= 1,680) when compared to a significantly decreasing blood lactate concentration (less than -1 mmom.L^-1^.24 hours^-1^, *n*= 1,482) (OR 1.66 (1.35 to 2.04), OR 1.29 (1.02 to 1.62) respectively).

###### 

Multivariate models for the prediction of hospital and ICU mortality

  Effect                                     Hospital mortality    *P*-value   ICU mortality         p-value
  ------------------------------------------ --------------------- ----------- --------------------- -----------
  APACHE II score                            1.13 (1.11 to 1.14)   \< 0.0001   1.13 (1.11 to 1.15)   \< 0.0001
  Age (yr)                                   1.02 (1.02 to 1.03)   \< 0.0001   1.01 (1.00 to 1.02)   0.004
  LAC~TW24~(mmom.L^-1^)                      1.37 (1.29 to 1.45)   \< 0.0001   1.43 (1.35 to 1.52)   \< 0.0001
  LAC~Δ24~(mmom.L^-1^)                       1.15 (1.10 to 1.20)   \< 0.0001   1.18 (1.13 to 1.24)   \< 0.0001
  Diagnosis\*                                                      \< 0.0001                         \< 0.0001
  Mechanical ventilation                     1.93 (1.52 to 2.45)   \< 0.0001   2.81 (1.95 to 4.05)   \< 0.0001
  Hospital\*                                                       0.0001                            0.006
  Admission date (decreased risk per year)   0.91 (0.83 to 0.99)   0.04        0.88 (0.78 to 1.00)   0.05
  Surgical patients                          0.67 (0.53 to 0.84)   0.0007      0.80 (0.59 to 1.08)   0.15
  Number of measurements                     0.98 (0.95 to 1.01)   0.23        1.01 (0.97 to 1.04)   0.76
  Female v male                              0.96 (0.81 to 1.14)   0.66        0.99 (0.79 to 1.23)   0.90

\*categorical variable, odds ratios excluded

APACHE II, Acute Physiology and Chronic Health Evaluation; LAC~TW24~, time weighted lactate; LAC~Δ24~, delta lactate-change in lactate in the first 24 hours

![**Adjusted\* odds ratios for Lac~Δ24~referenced against the lowest quintile**. \* adjusted for APACHE II, diagnosis, age, gender, ventilation, surgery, admission date, hospital number of measurements. 95% CI, 95% confidence interval; APACHE II, Acute Physiology and Chronic Health Evaluation II; LAC~Δ24~, delta lactate, change in lactate in the first 24 hours~;~Lac~Δ24~change in lactate over the first 24 hours.](cc10497-2){#F2}

For every one unit increase in LAC~TW24~the risk of hospital death increased by 37% (OR 1.37 (1.29 to 1.45) *P*\< 0.0001) and the risk of ICU mortality increased by 43% (OR 1.43 (1.35 to 1.52) *P*\< 0.0001). When LAC~TW24~was divided into quintiles and analysed as a categorical variable, each quintile progressively showed an increased risk in comparison to the lowest quintile for both hospital and ICU mortality (Figure [3](#F3){ref-type="fig"}).

![**Adjusted\* odds ratios for Lac~TW~referenced against the lowest quintile**. \* adjusted for APACHE II, diagnosis, age, gender, ventilation, surgery, admission date, hospital number of measurements. 95% CI, 95% confidence interval; APACHE II, Acute Physiology and Chronic Health Evaluation II; Lac~TW~, time weighted lactate over the first 24 hours.](cc10497-3){#F3}

When prediction equations excluding measurements of lactate were derived from 50% of the data and then applied to the remaining holdout sample, the AUC for hospital and ICU mortality was 0.820 ± 0.01 and 0.873 ± 0.01 respectively. The inclusion of static and dynamic measures of lactate homeostasis within the first 24 hours improved the prediction of hospital and ICU mortality (Table [4](#T4){ref-type="table"}). When LAC~TW24~and LAC~Δ24~were added to the models of hospital mortality, the AUC-ROC was found to increase to 0.831 ± 0.01 and 0.825 ± 0.009 respectively (Table [4](#T4){ref-type="table"}). In both cases, this represented a statistical (*P*\< 0.0001) improvement in the prediction of mortality.

###### 

Change in adjusted Area under the Receiver Operating Characteristic Curve

  NAME                             Hospital AUC~ADJ~   *P*-value\*   ICU AUC~ADJ~       *P*-value\*
  -------------------------------- ------------------- ------------- ------------------ -------------
  \(1\) Established risk factors   0.820 ± 0.01                      0.873 ± 0.01       
  \(1\) + LAC~ADM~                 0.822 ± 0.01        0.16          0.875 ± 0.01       0.24
  \(1\) + LAC~Δ24%~                0.824 ± 0.01        0.006         0.879 ± 0.01       0.009
  \(1\) + LAC~Δ24~                 0.825 ± 0.01        0.005         0.879 ± 0.01       0.03
  \(1\) + LAC~MAX24~               0.827 ± 0.01        0.007         0.883 ± 0.01       0.015
  \(1\) + LAC~TW24~                0.831 ± 0.01        0.0001        0.887 ± 0.01       0.0005
  \(1\) + LAC~MIN24~               0.832 ± 0.01        \< 0.0001     0.886 ± 0.01       \< 0.0001
                                                                                        
  \(1\) + LAC~TW~& LAC~Δ24~        0.838 ± 0.01\*\*    \< 0.0001     0.895 ± 0.01\*\*   \< 0.0001

\*compared to model (1) with established risk factors (APACHE II, diagnosis, age, gender, ventilation, surgery, date of admission and hospital)

\*\**P*\< 0.01 compared to all individual measure of lactate

APACHE II, Acute Physiology and Chronic Health Evaluation II; Apache II, diagnosis, age, gender, ventilation, surgery, date of admission, mortality adjusting for established predictors of mortality; AUC~ADJ~, adjusted Area under the Receiver Operating Characteristic Curve; HVHF, high-volume hemofiltration; LAC~ADM~, admission lactate; LAC~TW24~, time weighted lactate; LAC~MAX24~, maximum lactate; LAC~MIN24~, minimum lactate; LAC~Δ24~, delta lactate; LAC~%Δ24~, percentage change in lactate in the first 24 hours

Interestingly, when LAC~MIN~(a static measure) was added to the models of hospital mortality, the AUC was found to increase to 0.832 ± 0.01 (Table [4](#T4){ref-type="table"}). However, when we combined LAC~TW24~and LAC~Δ24~we found that this resulted in the greatest improvement in the prediction of both hospital and ICU mortality (Table [4](#T4){ref-type="table"}), compared to any other combination.

Discussion
==========

Statement of key findings
-------------------------

In a large multi-centre, heterogeneous cohort of critically ill patients, we examined whether dynamic indices of blood lactate concentration over the first 24 hours of ICU admission were independently associated with increased risk of hospital mortality. We found that LAC~TW24~and the LAC~Δ24~were the indices of lactate homeostasis within the first 24 hours that were independently the most predictive of hospital mortality. A rising, compared to a falling, blood lactate concentration over the first 24 hours was associated with a significantly increased risk of mortality. Furthermore, for every one mmol L^-1^increase in LAC~TW24~and in LAC~Δ24~the risk of hospital death increased by 37% and 15%, respectively. When LAC~TW24~and LAC~Δ24~were separately added to outcome prediction models, the AUC-ROC was found to increase significantly achieving close to 90% discrimination for ICU mortality. Furthermore, the maximal increase in AUC-ROC was achieved by the combination of both these dynamic indices (LAC~TW24~and LAC~Δ24~) achieving close to 90% discrimination for ICU mortality and close to 85% discrimination for hospital mortality

Comparison with previous studies-static versus dynamic
------------------------------------------------------

While quite a number of studies, including our previous study \[[@B4]\], have demonstrated that higher \"static\" indices of lactate derangement during ICU stay (LAC~TW24~, LAC~MAX24~and LAC~MIN24~) are associated with higher ICU and hospital mortality \[[@B1],[@B3],[@B4],[@B8],[@B12]\] only a few studies have reported dynamic indices of lactate homeostasis. In these studies, sustained hyperlactataemia (generally regarded as more than six hours) was associated with higher mortality and, as the duration of this hyperlactaemia increased, the mortality rate also increased \[[@B2],[@B5],[@B12],[@B13],[@B16],[@B17]\]. However, it must be noted that the majority of these studies were small, single centre, conducted in a single/specific diagnostic grouping (that is, severe sepsis), commonly examined for only short time periods after admission to ICU (under 24 hours) and were assessed in patients who had only a small number of lactate samples taken in the first 24 hours. These methodological deficiencies have confounded previous attempts to investigate the independent predictive value of dynamic indices of lactate in a heterogeneous population of critically ill patients. Our findings, however, for the first time demonstrate that early dynamic indices of lactate hoemeostasis (LAC~TW24~and the LAC~Δ24~) are independently associated with hospital mortality in a large heterogeneous cohort of patients. Our study expands this association between decreasing blood lactate concentrations and mortality to all patient groups and up to the first 24 hours in the critically ill. Thus, not only the magnitude and the duration of lactate derangement (LAC~TW24~) but also the rate of derangement in blood lactate concentration over the first 24 hours (LAC~Δ24~) help identify patients at higher risk of death. In this regard, our findings significantly expand previous work which suggested that dynamic changes in lactate concentration could be clinically useful markers of patients at high risk of death \[[@B1],[@B2],[@B5],[@B6],[@B24]\]. However, to facilitate comparison with these previous studies we conducted a separate analysis over the first six hours after ICU admission and demonstrated that lactate clearance was inversely associated with increased risk of death at both univariate (*P*= 0.0001) and multivariate levels (*P*= 0.007) (Figure [4](#F4){ref-type="fig"}). These findings suggest for the first time that LAC~Δ24~may be a clinically useful index of lactate homeostasis in the critically ill. While univariate results suggest a threshold value of 30 to 40% clearance over the first six hours, there is no clear indication from the multivariate model as the risk of death continues to decrease as the lactate clearance increases. Furthermore, these findings are consistent with previous studies suggesting that targeted reduction of lactate may be a beneficial strategy in the critically ill \[[@B14],[@B17]\]. We also examined lactate clearance at 6 to 12 hours, 12 to 18 hours and 18 to 24 hours, but it was not found to be statistically significant at either a univariate or multivariate level (data not shown). In addition, while the majority of the previous studies examined patients with sepsis/septic shock, our cohort was heterogeneous. While we determined those with sepsis had an increased risk of mortality OR 1.60 (1.06 to 2.41) *P*= 0.02, there was no significant interaction between sepsis and LAC~TW24~(*P*= 0.92) or sepsis and LAC~Δ24~(*P*= 0.10). This indicates that there was no evidence in this cohort to suggest that the relationship between lactate and mortality differed significantly between those with and without sepsis.

![**Raw and adjusted\* odds ratios (95% CI) for death with Lac~Δ6~referenced against zero change**. \* adjusted for APACHE II, diagnosis, age, gender, ventilation, surgery, admission date, hospital number of measurements. 95% CI, 95% confidence interval; APACHE II, Acute Physiology and Chronic Health Evaluation II; LAC~Δ24~, change in lactate in the first 24 hours; Lac~Δ6~, lactate clearance at six hours.](cc10497-4){#F4}

To our knowledge this is the first demonstration that dynamic measures of lactate can be used to significantly improve the prediction of mortality in a heterogeneous cohort of critically ill patients. Moreover, both LAC~TW24~and LAC~Δ24~were positively associated with length of stay in survivors suggesting that these indices are robust and identify patients not only at high risk of mortality but also those who are at high risk of significant morbidity (data not shown). While individual dynamic measures do not outperform all the currently used static measures, the combined measure of lactate dynamics (LAC~TW24~and LAC~Δ24~) could be the optimal early lactate variable to predict mortality as it can out-perform currently used static measures. This improved predictive ability may rest in the ability of this dynamic composite to assess the absolute magnitude, duration and rate of reduction of lactate derangement. Further studies are now required to confirm the clinical utility of this composite dynamic measure.

Implications for clinicians
---------------------------

There is much interest in finding biomarkers that can assist in the early identification of patients who are, or continue to be, at high risk of death \[[@B25]\]. Our findings suggest that dynamic changes in blood lactate concentration over the first 24 hours may prove useful as a widely available biomarker of increased risk of death. Interestingly, in support of this hypothesis, goal directed resuscitation in critically ill patients with septic shock improves blood lactate concentrations over its six hours of therapy \[[@B26]\]. Furthermore, a prospective study which targeted reductions in blood lactate concentration goals was equally effective as a strategy targeting central venous oxygen saturation \[[@B25],[@B27]\]. While our findings are in broad agreement with this association between \'physiological\' normalisation of lactate and improved survival in the critically ill, further study is required before our findings should be used as a therapeutic target in mixed cohorts of patients and over varying time periods. However, clinicians confronted with a persistently abnormal blood lactate should also be aware of the fact that the absolute degree of derangement (duration and magnitude) and the rate increase of this derangement are associated with risk of death and should continue to maintain a high index of suspicion until these parameters have completely normalised.

Limitations of the study
------------------------

Our study is retrospective in design and thus potentially subject to systematic error and bias. However, all the clinical and electronic data utilised were collected prospectively in a large number of consecutive critically ill patients in four ICUs, are numerical in nature and were measured independently; thus, they were not amenable to selection bias or unintended manipulation. Furthermore, 71% of all ICU patients admitted during the study period (*n*= 7,155) had at least two blood lactate measurements (*n*= 5,041) and were included in our analysis, suggesting that our findings are generalisable and can be applied to the majority of ICU patients. A number of common therapeutic interventions, such as epinephrine \[[@B28]\], metformin \[[@B29]\], nucleoside analogues in HIV \[[@B30]\], high-volume hemofiltration (HVHF) with lactate-buffered replacement fluids \[[@B31]\], can all affect lactate levels and we did not have information on their use. However, the influence of these potential confounding factors is likely to be negligible given the small numbers of patients in which these factors would have been present, in relation to the size of the cohort; although presence of these factors might alter the applicability of these results to individual patients.

While our calculation of LAC~Δ24~assumes that the kinetics of lactate is linear in nature, it is possible that it may follow an alternative decay profile, that is, exponential. However, we feel this pragmatic assumption does not positively bias the strength of the associations demonstrated. Furthermore, we believe that more complex modelling of lactate kinetics would obscure the take-home message for clinicians at the bedside of the association between rate of change of lactate concentration and mortality

The prognostic relevance of higher LAC~TW24~and LAC~Δ24~derives from the statistical examination of a large group of critically ill patients. Our results show that the inclusion of these variables can significantly improve the strength of predictive models of hospital mortality. This suggests that future investigators developing early prognostic models in the critically ill should consider the inclusion of these parameters (and the composite measure of both together). However, it must be noted that they should not be misused as a reliable prognostic sign in the individual patient, but in comparing groups of patients. In individual patients, higher LAC~TW24~and Lac~Δ24~, however, should be considered a useful indicator pointing to the severity of illness and to superimposed complications.

Future research
---------------

These dynamic lactate findings are novel and need to be confirmed by similar studies in other countries and large heterogeneous patient populations before they can be considered to reflect a general biological principle. Ideally, these studies should be conducted prospectively with simultaneous collection of information on interventions which may affect lactate. Furthermore, given the lactate indices assessed in this study are not necessarily the first in hospital lactate measurements and may not, therefore, consider the effects of early resuscitative interventions, future prospective studies should collect all lactate measurements (that is, including the emergency department) to determine if the demonstrated relationships are also observed during this earlier period.

In addition, if these studies confirm the value of LAC~Δ24~, then future studies could potentially focus on this marker as a surrogate endpoint to assess the success of early interventions in critically ill patients in the resuscitative period.

Future studies developing new or refining current severity of illness models in the critically ill should consider the inclusion of measures of lactate homeostasis in the first 24 hours. Our results suggest that the use of dynamic measures may result in the greatest improvement in predictive ability. In addition, it is worth noting that our study was potentially limited by having to add lactate measurements to the composite APACHE II score, rather than its component parts, and that a completely re-derived risk prediction equation that includes one or more index of lactate may further increase the predictive ability over that shown in this study.

Conclusions
===========

In conclusion, higher LAC~TW24~and LAC~Δ24~blood lactate concentrations are associated with greater hospital mortality. In the first 24 hours following ICU admission, they have significant independent predictive value, improve the performance of illness severity score-based outcome predictions and are superior to simple static measures of lactate concentration. Future studies should be conducted to determine the clinical utility of the composite measure of lactate derangement (magnitude, duration and rate of correction) to predict mortality and to determine potential the utility of LAC~Δ24~as a future therapeutic target/trigger. While these dynamic measures do not have a routine role in daily clinical practice, clinicians should be especially alert to all patients with a persistently deranged or rapidly rising blood lactate concentration.

Key messages
============

• Static derangements in lactate homeostasis during ICU stay have become established as clinically useful markers of increased risk of mortality.

• Dynamic indices of lactate homeostasis, which describe not only magnitude but also duration and trend over time, may be even more useful in predicting outcome.

• We demonstrated that higher lactate averaged over 24 hours (LAC~TW24~) and an increasing trend in lactate concentration over 24 hours (LAC~Δ24~) is associated with greater hospital mortality.

• Furthermore, the combination of these markers out-performed all individual \'static\' indices of lactate homeostasis in predicting outcome in the critically ill.

• Clinicians should be especially alert in all patients with a persistently deranged or rapidly rising blood lactate concentration
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